|
Re: Resverlogix Closes Previously Announced $87 Million Private Placement with Shenzhen Hepalink
|
5
|
Resverlogix Corp.
|
Dec 04, 2017 11:38AM
|
|
Re: Toxicity
|
5
|
Zenith Epigenetics
|
Mar 24, 2023 02:30PM
|
|
Re: Fist stamp of approval from FDA!!!
|
5
|
Resverlogix Corp.
|
Feb 03, 2020 11:26AM
|
|
Re: ZEN-3694 mCRPC Trial Status
|
5
|
Zenith Epigenetics
|
Oct 26, 2017 12:13PM
|
|
Re: Hump Day Fun
|
5
|
Resverlogix Corp.
|
Mar 31, 2023 01:33PM
|
|
Re: Actions Speak Louder Than Words
|
5
|
Resverlogix Corp.
|
Nov 27, 2016 05:14PM
|
|
Re: Sedar filings - Loan balance
|
5
|
Resverlogix Corp.
|
Jul 30, 2019 08:39AM
|
|
Re: Resverlogix to Present at the Clinical Trials on Alzheimer's Disease Congress 2019
|
5
|
Resverlogix Corp.
|
Dec 02, 2019 11:33AM
|
|
Re: New version of May slide deck and ERA-EDTA Conference & Symposium
|
5
|
Resverlogix Corp.
|
May 23, 2018 02:36PM
|
|
Re: The problem...as I see it cityslicker99
|
5
|
Resverlogix Corp.
|
Oct 17, 2020 05:36PM
|
|
Re: ORI developments ?? thanks to rndtbl
|
5
|
Resverlogix Corp.
|
Jan 23, 2021 02:12PM
|
|
Re: Management Information Circular...
|
5
|
Resverlogix Corp.
|
Nov 10, 2017 02:22AM
|
|
Re: Patient Enrollment Modeling
|
5
|
Resverlogix Corp.
|
Dec 02, 2018 12:58PM
|
|
Re: Hold or fold?
|
5
|
Resverlogix Corp.
|
Dec 17, 2020 05:38PM
|
|
Re: HOW LONG
|
5
|
Resverlogix Corp.
|
Jul 27, 2022 11:02AM
|
|
Re: Article on NASH Liver Disease
|
5
|
Resverlogix Corp.
|
Aug 18, 2019 03:53AM
|
|
Re: Two articles - Apabetalone for Colon Cancer?
|
5
|
Resverlogix Corp.
|
Jul 09, 2021 12:26PM
|
|
Re: Earliest minute/hour
|
5
|
Resverlogix Corp.
|
Sep 29, 2019 02:51PM
|
|
Is this bad for RVX but right, on the money?
|
5
|
Resverlogix Corp.
|
Apr 18, 2020 05:15PM
|
|
Re: what are the chances?
|
5
|
Resverlogix Corp.
|
Mar 24, 2022 03:23PM
|
